Carmazzi, Y <br/><br/>
The mechanisms of nadroparin-mediated inhibition of proliferation of two human lung cancer cell lines.  [electronic resource] 

 -  Cell proliferation  Dec 2012 
 - 545-56 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2184 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2184.2012.00847.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Anticoagulants--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Flow Cytometry<br/>Humans<br/>Lung--cytology<br/>Lung Neoplasms--drug therapy<br/>Nadroparin--pharmacology<br/>cdc25 Phosphatases--antagonists & inhibitors